2012.Jul.20
未分類
Corporate
DIFICID (Fidaxomicin) Approved by Taiwan Department of Health for the Treatment of CDAD
DIFICID® (Fidaxomicin) Approved by Taiwan Department of Health for the Treatment of Clostridium Difficile Associated Diarrhea (CDAD) TAIPEI, 20 July 2012 OBI Pharma, Inc. announced today that DIFICID® (Fidaxomicin) has been approved by Taiwan’s Department of Health for the treatment of Clostridium Difficile Associated Diarrhea (CDAD). DIFICID® is the first drug to be approved for […]
This article is password protected.
To view the content, please enter your password in the field below